News und Analysen
EQS-News: GRENKE presents study on the investment behaviour of retail investors
EQS-News: GRENKE presents study on the investment behaviour of retail investors
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process
EQS-News: CANCOM SE: Supervisory Board of the CANCOM Group reorganized
EQS-News: CANCOM SE: Supervisory Board of the CANCOM Group reorganized
EQS-Adhoc: CANCOM SE: Klaus Weinmann new Chairman of the Supervisory Board; previous Chairman of the Supervisory Board Stefan Kober resigns chairmanship
EQS-Adhoc: CANCOM SE: Klaus Weinmann new Chairman of the Supervisory Board; previous Chairman of the Supervisory Board Stefan Kober resigns chairmanship
EQS-News: MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
EQS-News: MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
EQS-News: 1&1 O-RAN: Launch of mobile services in Europe's most modern 5G network
EQS-News: 1&1 O-RAN: Launch of mobile services in Europe's most modern 5G network
EQS-Adhoc: CANCOM SE: Cancellation of acquired treasury shares and capital reduction
EQS-Adhoc: CANCOM SE: Cancellation of acquired treasury shares and capital reduction
EQS-News: CANCOM SE: CANCOM strengthens expertise in the area of complex IT infrastructure and managed services through the acquisition of significant parts of DextraData GmbH
EQS-News: CANCOM SE: CANCOM strengthens expertise in the area of complex IT infrastructure and managed services through the acquisition of significant parts of DextraData GmbH
EQS-News: Schaeffler AG and Vitesco Technologies Group AGSign Business Combination Agreement
EQS-News: Schaeffler AG and Vitesco Technologies Group AGSign Business Combination Agreement
EQS-Adhoc: Schaeffler AG: Conclusion of a Business Combination Agreement with Vitesco Technologies Group AG
EQS-Adhoc: Schaeffler AG: Conclusion of a Business Combination Agreement with Vitesco Technologies Group AG
EQS-News: GRENKE Corporate Governance scores top position in SDAX
EQS-News: GRENKE Corporate Governance scores top position in SDAX
EQS-News: 1&1 launches smartphone tariffs in its own mobile network on 8 December
EQS-News: 1&1 launches smartphone tariffs in its own mobile network on 8 December
EQS-News: GRENKE CEO Dr Sebastian Hirsch after one year in office: “Successful realignment”
EQS-News: GRENKE CEO Dr Sebastian Hirsch after one year in office: “Successful realignment”
EQS-Adhoc: GRENKE AG: GRENKE applies for approval of share buyback program
EQS-Adhoc: GRENKE AG: GRENKE applies for approval of share buyback program
EQS-News: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
EQS-News: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
EQS-Adhoc: Ad hoc: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
EQS-Adhoc: Ad hoc: MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction
EQS-News: Schaeffler AG appoints Dr. Astrid Fontaine as Chief Human Resources Officer
EQS-News: Schaeffler AG appoints Dr. Astrid Fontaine as Chief Human Resources Officer
EQS-News: MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
EQS-News: MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
EQS-News: Nagarro posts 12.9% YoY constant-currency revenue growth in 9M 2023
EQS-News: Nagarro posts 12.9% YoY constant-currency revenue growth in 9M 2023
EQS-News: PATRIZIA 9M 2023 results: Resilient AUM and solid third quarter performance – management adjusts cost base to prepare for a longer and slower market recovery and to increase recurring profitability
EQS-News: PATRIZIA 9M 2023 results: Resilient AUM and solid third quarter performance – management adjusts cost base to prepare for a longer and slower market recovery and to increase recurring profitability
EQS-Adhoc: PATRIZIA SE: Solid 9M 2023 results but continued market uncertainties - initiation of cost programme impacting FY 2023 EBITDA and improving FY 2024 earnings quality
EQS-Adhoc: PATRIZIA SE: Solid 9M 2023 results but continued market uncertainties - initiation of cost programme impacting FY 2023 EBITDA and improving FY 2024 earnings quality
EQS-News: 1&1 with good operating performance in the first 9 months of 2023
EQS-News: 1&1 with good operating performance in the first 9 months of 2023